Avidity Biosciences Statistics Share Statistics Avidity Biosciences has 120.54M
shares outstanding. The number of shares has increased by 2.92%
in one year.
Shares Outstanding 120.54M Shares Change (YoY) 2.92% Shares Change (QoQ) 0.27% Owned by Institutions (%) 99.99% Shares Floating 117.11M Failed to Deliver (FTD) Shares 4,334 FTD / Avg. Volume 0.19%
Short Selling Information The latest short interest is 16.26M, so 13.49% of the outstanding
shares have been sold short.
Short Interest 16.26M Short % of Shares Out 13.49% Short % of Float 13.62% Short Ratio (days to cover) 6.86
Valuation Ratios The PE ratio is -10.07 and the forward
PE ratio is -10.53.
Avidity Biosciences's PEG ratio is
14.65.
PE Ratio -10.07 Forward PE -10.53 PS Ratio 297.77 Forward PS 376.3 PB Ratio 2.28 P/FCF Ratio -10.54 PEG Ratio 14.65
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Avidity Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 15.73,
with a Debt / Equity ratio of 0.
Current Ratio 15.73 Quick Ratio 15.73 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $27.87K Profits Per Employee $-824.3K Employee Count 391 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 2.83% in the
last 52 weeks. The beta is 0.95, so Avidity Biosciences's
price volatility has been higher than the market average.
Beta 0.95 52-Week Price Change 2.83% 50-Day Moving Average 33.33 200-Day Moving Average 33.54 Relative Strength Index (RSI) 74.46 Average Volume (20 Days) 2,237,841
Income Statement In the last 12 months, Avidity Biosciences had revenue of 10.9M
and earned -322.3M
in profits. Earnings per share was -2.89.
Revenue 10.9M Gross Profit 10.9M Operating Income -378.94M Net Income -322.3M EBITDA -376.16M EBIT -378.94M Earnings Per Share (EPS) -2.89
Full Income Statement Balance Sheet The company has 219.87M in cash and 6.8M in
debt, giving a net cash position of 213.07M.
Cash & Cash Equivalents 219.87M Total Debt 6.8M Net Cash 213.07M Retained Earnings -893.07M Total Assets 1.46B Working Capital 1.35B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -300.87M
and capital expenditures -7.07M, giving a free cash flow of -307.94M.
Operating Cash Flow -300.87M Capital Expenditures -7.07M Free Cash Flow -307.94M FCF Per Share -2.76
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -3477.43% and -2957.71%.
Gross Margin 100% Operating Margin -3477.43% Pretax Margin -2957.71% Profit Margin -2957.71% EBITDA Margin -3451.96% EBIT Margin -3477.43% FCF Margin -2825.88%
